Highlights
NASDAQ: HALO       Halozyme Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
28.31   -0.58 (2.01%)  27.97 - 28.86  380,216

Overview

 
Avg Volume (4 weeks):1,310,610
4 Weeks Range:25.70 - 31.64
4 Weeks Price Volatility (%):
43.94%
52 Weeks Range:12.71 - 31.64
52 Weeks Price Volatility (%):
82.41%
Average Price Target: 6.50
Price Target Upside/Downside: -21.81

Headlines



No recent Headlines for this stock.


Business Background

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2060  3846  351  3139 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 BLRX 2.57+1.09 
 AAPL 108.956-6.364 
 NIO 30.83-1.16 
 OAS 0.155-0.014 
 SQQQ 25.075+1.715 
 TWTR 41.928-10.502 
 GE 7.370.00 
 HTZ 1.780.00 
 NOK 3.375+0.025